
Boosting Melanoma Immunity with Sequential IL-2 an...
Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapy—using the body’s own immun...
Learn about our rebrand Learn More
Washington, DC (January 27, 2025) – The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma, is excited to announce the official ...
Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapy—using the body’s own immun...
Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, brings that survival rate down to 50%....
Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The presence of microsatellitosis has been ...
Apr 26, 2025 - Apr 27, 2025